WEBSITE BSE:531253 NSE : INDIA GELAT. 18 May, 12:50
Market Cap ₹278 Cr.
Stock P/E 9.8
P/B 1.8
Current Price ₹392
Book Value ₹ 217.2
Face Value 10
52W High ₹514
Dividend Yield 2.81%
52W Low ₹ 255.3
India Gelatine & Chemicals Ltd is a prominent company engaged in the production and distribution of gelatin and other chemicals. With a strong presence in the chemical industry, the company operates in various sectors, including pharmaceuticals, food and beverage, cosmetics, and industrial applications. India Gelatine & Chemicals is recognized for its commitment to high-quality products and customer satisfaction. The company's core product, gelatin, is a versatile ingredient widely used in pharmaceutical capsules, confectionery items, dairy products, photographic films, and more. India Gelatine & Chemicals ensures stringent quality control measures throughout the manufacturing process, adhering to international standards and regulations. The company maintains state-of-the-art facilities and utilizes advanced technologies to deliver reliable and consistent products to its clients. With a robust distribution network, India Gelatine & Chemicals Ltd caters to both domestic and international markets, exporting its products to several countries. The company's success is driven by its dedicated team, innovative research and development initiatives, and a customer-centric approach, making it a trusted name in the gelatin and chemical industry.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 44 | 52 | 45 | 47 | 56 | 57 | 58 | 49 | 48 | 51 |
Other Income | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 3 | 2 |
Total Income | 45 | 53 | 45 | 48 | 58 | 57 | 60 | 51 | 50 | 53 |
Total Expenditure | 42 | 48 | 40 | 42 | 46 | 44 | 46 | 41 | 40 | 44 |
Operating Profit | 3 | 6 | 5 | 6 | 11 | 14 | 15 | 9 | 10 | 9 |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | 2 | 4 | 4 | 5 | 10 | 13 | 13 | 8 | 9 | 7 |
Provision for Tax | 1 | 1 | 1 | 1 | 3 | 3 | 3 | 3 | 1 | 2 |
Profit After Tax | 1 | 3 | 3 | 4 | 8 | 9 | 10 | 6 | 8 | 5 |
Adjustments | 0 | 0 | -0 | 0 | 0 | 0 | -0 | 0 | 0 | -0 |
Profit After Adjustments | 1 | 3 | 3 | 4 | 8 | 9 | 10 | 6 | 8 | 5 |
Adjusted Earnings Per Share | 1.5 | 4.6 | 4.1 | 5.7 | 10.8 | 13.1 | 14.2 | 7.8 | 11 | 7.1 |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 117 | 121 | 115 | 94 | 74 | 98 | 112 | 132 | 144 | 160 | 205 | 206 |
Other Income | 3 | 3 | 7 | 5 | 6 | 4 | 4 | 3 | 5 | 4 | 3 | 9 |
Total Income | 120 | 124 | 122 | 99 | 80 | 102 | 116 | 135 | 149 | 164 | 208 | 214 |
Total Expenditure | 98 | 106 | 110 | 90 | 74 | 96 | 107 | 125 | 135 | 153 | 172 | 171 |
Operating Profit | 22 | 18 | 12 | 9 | 6 | 6 | 9 | 10 | 13 | 11 | 37 | 43 |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
Depreciation | 5 | 5 | 5 | 5 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 5 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | 17 | 12 | 7 | 5 | 3 | 3 | 6 | 6 | 9 | 7 | 32 | 37 |
Provision for Tax | 6 | 4 | 1 | 1 | -0 | 0 | -0 | 1 | 2 | 2 | 8 | 9 |
Profit After Tax | 11 | 8 | 6 | 4 | 3 | 2 | 6 | 5 | 7 | 6 | 24 | 29 |
Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 |
Profit After Adjustments | 11 | 8 | 6 | 4 | 3 | 2 | 5 | 5 | 7 | 6 | 24 | 29 |
Adjusted Earnings Per Share | 12.1 | 8.6 | 6.6 | 3.9 | 3.4 | 3.2 | 8.1 | 7.6 | 10 | 7.9 | 33.7 | 40.1 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | 28% | 16% | 16% | 6% |
Operating Profit CAGR | 236% | 55% | 44% | 5% |
PAT CAGR | 300% | 69% | 64% | 8% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | 51% | 51% | 33% | 18% |
ROE Average | 19% | 10% | 8% | 7% |
ROCE Average | 25% | 14% | 11% | 9% |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Shareholder's Funds | 108 | 114 | 119 | 121 | 124 | 99 | 102 | 104 | 110 | 115 | 136 |
Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8 |
Other Non-Current Liabilities | 24 | 17 | 17 | 22 | 10 | 9 | 9 | 9 | 9 | 10 | 12 |
Total Current Liabilities | 18 | 16 | 18 | 14 | 7 | 7 | 5 | 11 | 7 | 12 | 24 |
Total Liabilities | 150 | 148 | 154 | 157 | 141 | 115 | 116 | 124 | 127 | 136 | 180 |
Fixed Assets | 52 | 49 | 47 | 45 | 44 | 42 | 42 | 43 | 40 | 41 | 60 |
Other Non-Current Assets | 31 | 21 | 22 | 22 | 7 | 6 | 8 | 11 | 17 | 17 | 26 |
Total Current Assets | 67 | 78 | 84 | 90 | 90 | 68 | 66 | 69 | 69 | 79 | 94 |
Total Assets | 150 | 148 | 154 | 157 | 141 | 115 | 116 | 124 | 127 | 136 | 180 |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Opening Cash & Cash Equivalents | 22 | 15 | 13 | 31 | 41 | 9 | 1 | 3 | 4 | 3 | 2 |
Cash Flow from Operating Activities | 5 | -1 | 17 | 4 | -4 | 15 | 5 | 7 | 6 | 9 | 18 |
Cash Flow from Investing Activities | -10 | 2 | 3 | 8 | -27 | -19 | -1 | -3 | -6 | -8 | -21 |
Cash Flow from Financing Activities | -3 | -3 | -2 | -2 | -1 | -1 | -2 | -3 | -1 | -2 | 7 |
Net Cash Inflow / Outflow | -7 | -2 | 18 | 10 | -32 | -5 | 2 | 1 | -1 | -1 | 3 |
Closing Cash & Cash Equivalent | 15 | 13 | 31 | 41 | 9 | 3 | 3 | 4 | 3 | 2 | 5 |
# | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Earnings Per Share (Rs) | 12.13 | 8.57 | 6.62 | 3.9 | 3.37 | 3.18 | 8.11 | 7.55 | 10.03 | 7.91 | 33.7 |
CEPS(Rs) | 17.32 | 14.31 | 12.06 | 8.95 | 6.99 | 7.74 | 12.82 | 12.4 | 15.18 | 12.99 | 39.13 |
DPS(Rs) | 3 | 1.8 | 1.5 | 0.9 | 0.9 | 2 | 3.5 | 1.5 | 2.5 | 2.5 | 5 |
Book NAV/Share(Rs) | 115.22 | 121.69 | 126.07 | 128.88 | 131.95 | 139.11 | 144.21 | 146.93 | 155.23 | 161.73 | 192.33 |
Core EBITDA Margin(%) | 16.04 | 12.48 | 4.89 | 4.66 | 0.76 | 1.61 | 4.86 | 4.96 | 5.86 | 4.59 | 16.28 |
EBIT Margin(%) | 14.44 | 10.2 | 6.2 | 4.96 | 3.99 | 2.75 | 5.08 | 4.98 | 6.57 | 4.71 | 15.94 |
Pre Tax Margin(%) | 14.39 | 10.19 | 6.2 | 4.95 | 3.99 | 2.75 | 5.07 | 4.86 | 6.45 | 4.59 | 15.63 |
PAT Margin (%) | 9.64 | 6.59 | 5.34 | 3.83 | 4.19 | 2.3 | 5.14 | 4.06 | 4.94 | 3.51 | 11.65 |
Cash Profit Margin (%) | 13.77 | 11.01 | 9.73 | 8.8 | 8.69 | 5.6 | 8.12 | 6.67 | 7.48 | 5.76 | 13.52 |
ROA(%) | 7.97 | 5.42 | 4.12 | 2.36 | 2.13 | 1.76 | 4.97 | 4.47 | 5.68 | 4.27 | 15.11 |
ROE(%) | 10.94 | 7.23 | 5.34 | 3.06 | 2.58 | 2.03 | 5.73 | 5.19 | 6.64 | 4.99 | 19.03 |
ROCE(%) | 16.35 | 11.18 | 6.2 | 3.95 | 2.46 | 2.42 | 5.67 | 6.36 | 8.82 | 6.7 | 25.05 |
Receivable days | 25.19 | 21.17 | 16.11 | 19.11 | 25.65 | 16.8 | 15.91 | 16.18 | 19.97 | 23.79 | 22.5 |
Inventory Days | 59.93 | 76.53 | 89.6 | 100.87 | 131.95 | 105.92 | 82.74 | 73.91 | 71.71 | 65.13 | 62.62 |
Payable days | 39.89 | 31.9 | 23.23 | 21.98 | 43.69 | 42.03 | 33.32 | 35.55 | 32.03 | 30.2 | 47.69 |
PER(x) | 5.66 | 7.91 | 10.54 | 18.85 | 25.18 | 30.43 | 10.58 | 10.59 | 8.98 | 13.82 | 8.13 |
Price/Book(x) | 0.6 | 0.56 | 0.55 | 0.57 | 0.64 | 0.7 | 0.6 | 0.54 | 0.58 | 0.68 | 1.42 |
Dividend Yield(%) | 4.37 | 2.66 | 2.15 | 1.22 | 1.06 | 2.07 | 4.08 | 1.88 | 2.78 | 2.29 | 1.82 |
EV/Net Sales(x) | 0.43 | 0.42 | 0.3 | 0.3 | 0.96 | 0.67 | 0.49 | 0.38 | 0.4 | 0.45 | 0.95 |
EV/Core EBITDA(x) | 2.28 | 2.85 | 2.83 | 3.01 | 11.07 | 11.01 | 6.13 | 4.95 | 4.41 | 6.41 | 5.34 |
Net Sales Growth(%) | 13.38 | 3.25 | -4.53 | -18.36 | -21.07 | 31.39 | 14.56 | 17.79 | 9.07 | 11.1 | 28.38 |
EBIT Growth(%) | 73.07 | -27.01 | -42.09 | -34.36 | -36.28 | -10.55 | 110.9 | 15.3 | 43.91 | -20.24 | 334.2 |
PAT Growth(%) | 61.22 | -29.35 | -22.8 | -41.07 | -13.56 | -28.77 | 155.06 | -6.93 | 32.76 | -21.08 | 325.91 |
EPS Growth(%) | 61.22 | -29.35 | -22.8 | -41.07 | -13.56 | -5.6 | 155.06 | -6.93 | 32.76 | -21.08 | 325.91 |
Debt/Equity(x) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.07 |
Current Ratio(x) | 3.76 | 4.84 | 4.57 | 6.61 | 12.89 | 9.12 | 13.97 | 6.59 | 9.63 | 6.58 | 3.88 |
Quick Ratio(x) | 2.46 | 3.08 | 3 | 4.85 | 8.49 | 5.6 | 8.79 | 3.85 | 5.77 | 4.12 | 2.18 |
Interest Cover(x) | 312.65 | 1452.52 | 8645.41 | 2843.92 | 773.85 | 613.55 | 462.89 | 41.55 | 56.07 | 39.43 | 50.41 |
Total Debt/Mcap(x) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.05 |
# | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 61.38 | 61.38 | 61.38 | 61.38 | 61.43 | 61.44 | 61.44 | 61.44 | 61.44 | 61.44 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DII | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Public | 38.61 | 38.61 | 38.61 | 38.61 | 38.56 | 38.55 | 38.55 | 38.55 | 38.55 | 38.55 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
# | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 0.44 | 0.44 | 0.44 | 0.44 | 0.44 | 0.44 | 0.44 | 0.44 | 0.44 | 0.44 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Public | 0.27 | 0.27 | 0.27 | 0.27 | 0.27 | 0.27 | 0.27 | 0.27 | 0.27 | 0.27 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 0.71 | 0.71 | 0.71 | 0.71 | 0.71 | 0.71 | 0.71 | 0.71 | 0.71 | 0.71 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Sell or Purchase Share (Tentative Price)
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About